Delcath also intends to grant the underwriters an option to purchase up to 15% of additional shares of primary stock to cover over-allotments.
Cowen and Company, LLC is acting as the book-running manager for the offering. Canaccord Adams, Inc., Wedbush Morgan Securities, Inc. and Craig-Hallum Capital Group LLC are acting as co-managers.
Deal Type IPO Sub-Category Secondary Offering Deal Status Announced: 2009-10-27
Deal Participants
Target (Company) Delcath Systems, Inc.
Deal Rationale
Delcath intends to use the proceeds from the offering for general corporate purposes including regulatory approval, commercialization, clinical trials, capital expenditures and working capital.
No. Shares Issued 8500000

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index